InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Knie Robb. Officer active across 1 company, notably Hoth Therapeutics, Inc.. In total, 4 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €23k. Activity tracked since 16 September 2022. The latest transaction was disclosed on 27 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Knie Robb is a declarant linked to Hoth Therapeutics, Inc. (XNAS), where the listed role is CEO and President. Across 4 total filings, the 4 sampled filings cover the period from 2022-09-19 to 2025-08-28, with acquisitions totaling EUR 23158 and no sales.